Y, L., X, Y., J, L., X, L., & S, W. (2019). CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Lin, Yang X, Lv J, Liu X, y Wang S. CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients. Dove Medical Press, 2019.
Cita MLA (8a ed.)Y, Lin, et al. CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients. Dove Medical Press, 2019.
Precaución: Estas citas no son 100% exactas.